PURPOSE: To reveal the incidence and degree of intrahepatic periportal high intensity (PHI) on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI (EOB-MRI) in patients with or without various hepatobiliary diseases. MATERIALS AND METHODS: Patients with normal liver (N = 256) and those with hepatic disorder (N = 857) who underwent EOB-MRI were the subjects in this study. Incidence of PHI was evaluated among the patients with normal liver and those with hepatic disorder. Degree of PHI was categorized into four grades and compared among the various hepatic diseases. Enhancement ratios (ER) of the PHI area, background liver with PHI, and background liver in control cases without PHI were evaluated. RESULTS: PHI was observed in 2.7 % of the patients with hepatic disorder. No PHI was observed in the patients with normal liver. The incidence rates of PHI among various hepatobiliary diseases were as follows; liver cirrhosis 3.1 %, chronic hepatitis 1.0 %, primary biliary cirrhosis 12.5 %, idiopathic portal hypertension 33.3 %. The ER of the PHI area and background liver were 3.92 and 2.48 (p = 0.0002). There were no significant differences between the ER of the PHI area and the ER of background liver in the noncirrhotic control without PHI. CONCLUSION: In 2.7 % of the patients with a hepatic disorder, the periportal area was saved from decrease of EOB uptake and it showed PHI.
PURPOSE: To reveal the incidence and degree of intrahepatic periportal high intensity (PHI) on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI (EOB-MRI) in patients with or without various hepatobiliary diseases. MATERIALS AND METHODS:Patients with normal liver (N = 256) and those with hepatic disorder (N = 857) who underwent EOB-MRI were the subjects in this study. Incidence of PHI was evaluated among the patients with normal liver and those with hepatic disorder. Degree of PHI was categorized into four grades and compared among the various hepatic diseases. Enhancement ratios (ER) of the PHI area, background liver with PHI, and background liver in control cases without PHI were evaluated. RESULTS: PHI was observed in 2.7 % of the patients with hepatic disorder. No PHI was observed in the patients with normal liver. The incidence rates of PHI among various hepatobiliary diseases were as follows; liver cirrhosis 3.1 %, chronic hepatitis 1.0 %, primary biliary cirrhosis 12.5 %, idiopathic portal hypertension 33.3 %. The ER of the PHI area and background liver were 3.92 and 2.48 (p = 0.0002). There were no significant differences between the ER of the PHI area and the ER of background liver in the noncirrhotic control without PHI. CONCLUSION: In 2.7 % of the patients with a hepatic disorder, the periportal area was saved from decrease of EOB uptake and it showed PHI.
Authors: T Kim; T Murakami; Y Hasuike; M Gotoh; N Kato; M Takahashi; T Miyazawa; Y Narumi; M Monden; H Nakamura Journal: J Magn Reson Imaging Date: 1997 Jul-Aug Impact factor: 4.813
Authors: Susan C Abraham; Patrick S Kamath; Bijan Eghtesad; Anthony J Demetris; Alyssa M Krasinskas Journal: Am J Surg Pathol Date: 2006-11 Impact factor: 6.394
Authors: A Scardapane; M Ficco; C Sabbà; F Lorusso; M Moschetta; N Maggialetti; P Suppressa; G Angelelli; A A Stabile Ianora Journal: Radiol Med Date: 2012-02-10 Impact factor: 3.469
Authors: Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg Journal: Invest Radiol Date: 2008-07 Impact factor: 6.016
Authors: Katharina Lampichler; Georg Semmler; Katharina Wöran; Benedikt Simbrunner; Mathias Jachs; Lukas Hartl; David Josef Maria Bauer; Lorenz Balcar; Lukas Burghart; Michael Trauner; Dietmar Tamandl; Ahmed Ba-Ssalamah; Mattias Mandorfer; Thomas Reiberger; Bernhard Scheiner; Martina Scharitzer Journal: Eur Radiol Date: 2022-09-27 Impact factor: 7.034
Authors: Hiromitsu Onishi; Daniel Theisen; Reinhart Zachoval; Maximilian F Reiser; Christoph J Zech Journal: Medicine (Baltimore) Date: 2019-03 Impact factor: 1.817